IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C

Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes

(2014) Zhangping Yang et al.   ACTA DIABETOLOGICA

miR-217 is an oncogene that enhances the germinal center reaction

(2014) V. G. de Yebenes et al.   BLOOD

Improving performance of liver biopsy in fibrosis assessment

(2014) Tarik Asselah et al.   JOURNAL OF HEPATOLOGY

Reduction of MicroRNA 122 Expression in IFNL3 CT/TT Carriers and during Progression of Fibrosis in Patients with Chronic Hepatitis C

(2014) E. Estrabaud et al.   JOURNAL OF VIROLOGY

MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis

(2013) Fanni Gelley et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Interferon-Inducible Protein IFI35 Negatively Regulates RIG-I Antiviral Signaling and Supports Vesicular Stomatitis Virus Replication

(2013) A. Das et al.   JOURNAL OF VIROLOGY

Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir

(2013) Tarik Asselah et al.   LIVER INTERNATIONAL

HCV direct-acting antiviral agents: the best interferon-free combinations

(2013) Raymond Schinazi et al.   LIVER INTERNATIONAL

Treatment of HCV Infection by Targeting MicroRNA

(2013) Harry L.A. Janssen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity

(2012) B. Zhou et al.   DIABETOLOGIA

Genomics and HCV infection: Progression of fibrosis and treatment response

(2012) Emilie Estrabaud et al.   JOURNAL OF HEPATOLOGY

The microcosmos of cancer

(2012) Amaia Lujambio et al.   NATURE

MIR-99a and MIR-99b Modulate TGF-β Induced Epithelial to Mesenchymal Plasticity in Normal Murine Mammary Gland Cells

(2012) Gianluca Turcatel et al.   PLoS One

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

(2011) Marc G. Ghany et al.   HEPATOLOGY

MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma

(2011) Dong Li et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

(2011)   JOURNAL OF HEPATOLOGY

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

(2011) Tarik Asselah et al.   JOURNAL OF HEPATOLOGY

Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C

(2010) Yoshiki Murakami et al.   BMC Medical Genomics

MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor

(2010) Li-Hua Zhu et al.   FEBS Journal

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

(2010) Alexander J. Thompson et al.   GASTROENTEROLOGY

Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C

(2010) Masao Honda et al.   GASTROENTEROLOGY

Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C

(2010) Michael T. Dill et al.   GASTROENTEROLOGY

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C

(2010) Thomas J. Urban et al.   HEPATOLOGY

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients

(2010) Christoph Sarrazin et al.   JOURNAL OF HEPATOLOGY

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy

(2010) Hiromi Abe et al.   JOURNAL OF HEPATOLOGY

Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers

(2009) Xinxia Peng et al.   BMC GENOMICS

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

(2009) Magdalena Sarasin-Filipowicz et al.   NATURE MEDICINE

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

(2009) R. E. Lanford et al.   SCIENCE

Significant gene expression differences in histologically “Normal” liver biopsies: Implications for control tissue

(2008) Tarik Asselah et al.   HEPATOLOGY

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

(2008) Shunsuke Ura et al.   HEPATOLOGY

Interferon signaling and treatment outcome in chronic hepatitis C

(2008) M. Sarasin-Filipowicz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA